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Type 2 diabetes (T2M) arises when insulin resistance and beta cell dysfunction develop in the context of over nutrition and weight gain [1]. Several mechanisms have been proposed to explain the evolution towards diabetes, including oxidative stress, endoplasmic reticulum (ER) stress, lipotoxicity, and glucotoxicity [2]. Although individual studies pinpoint the importance of each of these factors in the pathogenesis of diabetes in rodents, progression towards T2M in humans is polyfactorial. Inflammation in the hypothalamus, liver, adipose tissue and the pancreas arises now as a potential link between these conditions. Two recent studies shed important information on how macrophages control lipid-induced inflammation. Macrophages have been the first immune cells identified in mouse [3] and human [4] adipose tissue. An increase in the number of macrophages has also been demonstrated in pancreatic islets of T2M patients, as well as in diet induced animal models of obesity [5]. Macrophages infiltrating visceral adipose tissue belong to the M1 pro-inflammatory myeloid subtype, whereas those infiltrating subcutaneous adipose tissue are predominantly of the anti-inflammatory M2 subtype [6]. This observation might in part explain the reason why some obese individuals remain metabolically healthy while others develop diabetes and cardiovascular disease. What dictates the differentiation of macrophages into the M1 or M2 subtypes was poorly understood. A study published by the laboratory of Shizuo Akira has now characterized Trib1, an adaptor protein of the pseudokinase tribble family involved in protein degradation, as a critical factor for macrophage differentiation into the M2 subtype [7]. Trib1 deficient mice showed a defect in M2-like macrophage generation (as well as eosinophil differentiation). These mice had a diminished adipose tissue mass but augmented lipolysis, and this was accompanied by decreased glucose tolerance. Reconstitution of the Trib1 deficient mice with Trib1+/+ M2 macrophages abrogated these defects. This indicates that lipodystrophy and glucose intolerance in the Trib1 KO mice were a consequence of a lack in M2 macrophages. Possibly, production of IL-10 by M2 macrophages is important in this context as this cytokine is known to protect against insulin resistance [8]. This study may have important implications for humans as genome wide association studies have implicated Trib1 in metabolic disorders [9]. In contrast to M2 macrophages, M1 macrophages promote inflammation. Work from the laboratory of Roger Davis now shows that the JNK MAPK pathway in those macrophages is responsible for the induction of inflammation and insulin resistance triggered by obesity [10]. Macrophage-specific JNK deficiency led to improved glucose tolerance and reduced inflammation in mice fed a high-fat diet. This prevented the accumulation of M1 macrophages in adipose tissues but, interestingly, did not affect the infiltration of M2 macrophages in these tissues. It thus appears that peripheral insulin resistance or beta cells dysfunction can be caused by FFAs and JNK-induced polarization of macrophages towards the M1 subtype in fat tissues. This is an example of inter-organ cross-talk participating in the development of metabolic diseases.   
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Signalling through JNK in insulin-sensitive tissues leads to decreased glucose tolerance and 
diabetes onset. Mechanistically, JNKs promote insulin resistance by phosphorylating the 
insulin receptor substrate (IRS) adaptor proteins, hampering efficient signaling downstream of 
the insulin receptor. JNK signaling in the central nervous system also favors insulin resistance 
by promoting obesity. The authors of this study now provide evidence that JNKs contribute to 
insulin resistance by favoring the differentiation of macrophages into the pro-inflammatory 
M1 subtype. Macrophage-specific JNK deficiency was found to be associated with secretion 
of anti-inflammatory cytokines by epididymal adipose tissue and improved overall glucose 
tolerance. These results point towards a pivotal role played by macrophages in modulating 
adipose inflammation and peripheral insulin sensitivity. It was suggested earlier that targeting 
the JNK MAPK pathway could be efficacious against obesity and insulin resistance 
development by restoring insulin sensitivity in the central nervous system, skeletal muscles 
and adipocytes. The present study indicates that inhibiting JNK MAPK signaling in another 
cell type – the macrophages - also contributes to the prevention of obesity-induced insulin 
resistance by limiting inflammation in adipose tissues. Hence, JNK inhibitory drugs may 
generate independent beneficial actions against obesity-mediated dysfunctions by targeting, 
insulin-sensitive tissues, neurons, and cells that control inflammation.    
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